Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives
Pediatric Blood & Cancer · 2025-08 · 72 (8)
DOI: 10.1002/pbc.31790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 14.05.2025. Verfasst von Kathryn S Sutton und 18 weiteren Autor:innen. Beteiligte Einrichtung: Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Kidney Neoplasms, Neoplasm Recurrence, Local, Wilms Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: St. Baldrick's Foundation, NCTN Statistics & Data Center Grant, NCTN operations center grant.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Wilms tumor (WT) is the most common pediatric renal tumor, and with multidisciplinary treatment overall outcomes are excellent. However, a small subset of patients with WT will relapse. The ideal treatment of relapsed WT is yet to be defined. Ongoing studies through the Children's Oncology Group Renal Tumors Committee (COG‐RTC) and the International Society of Paediatric Oncology Renal Tumor Study Group (SIOP‐RTSG) aim to improve risk stratification and treatment strategies. Members met at the SIOP 55th Annual Congress 2023 to outline available data and knowledge gaps and develop future research priorities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
- Division of Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplant, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, I…
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Kathryn S Sutton, Amy L Walz, Andrew J Murphy, Filippo Spreafico, Justine van der Beek, Marc Hwa Wijnen, Max Pachl, Peter F Ehrlich, James Geller
Förderung
- St. Baldrick's Foundation
- NCTN Statistics & Data Center Grant
- NCTN operations center grant
- NCI NIH HHS
Zitieren
APA
Sutton, K. S., Walz, A. L., Groenendijk, A., Murphy, A. J., Pater, L., Janssens, G. O., Brzezinski, J., Mullen, E. A., Spreafico, F., Godzinski, J., van der Beek, J., Hwa Wijnen, M., van den Heuvel-Eibrink, M. M., Pachl, M., Graf, N., Ehrlich, P. F., Furtwangler, R., Brok, J., & Geller, J. (2025). Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood & Cancer, 72(8). https://doi.org/10.1002/pbc.31790
Vancouver
Sutton KS, Walz AL, Groenendijk A, Murphy AJ, Pater L, Janssens GO, et al. Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood & Cancer. 2025;72(8). doi:10.1002/pbc.31790
BibTeX
@article{Sutton2025,
author = {Sutton, Kathryn S and Walz, Amy L and Groenendijk, Alissa and Murphy, Andrew J and Pater, Luke and Janssens, Geert O and Brzezinski, Jack and Mullen, Elizabeth A and Spreafico, Filippo and Godzinski, Jan and van der Beek, Justine and Hwa Wijnen, Marc and van den Heuvel-Eibrink, Marry M and Pachl, Max and Graf, Norbert and Ehrlich, Peter F and Furtwangler, Rhoikos and Brok, Jesper and Geller, James},
title = {Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives},
journal = {Pediatric Blood & Cancer},
year = {2025},
volume = {72},
number = {8},
doi = {10.1002/pbc.31790}
}
EUVIMED